California Colorectal Cancer Coalition

California Colorectal Cancer Coalition

Our Mission: To save lives and reduce suffering from colorectal cancer in all Californians

T (619) 316-8751
Email: info@cacoloncancer.org

California Colorectal Cancer Coalition
2253 Soledad Rancho Rd, San Diego, CA 92109

OUR MISSION: TO SAVE LIVES AND REDUCE SUFFERING FROM COLORECTAL CANCER IN ALL CALIFORNIANS
  • No products in cart.
  • ABOUT CRC
    • Educational Resources
      • Colorectal Cancer Screening Reference List
      • California Cancer Registry
      • Healthcare Provider Resources
      • CME for Providers
      • Colorectal Cancer Symptoms
      • CDC Screening for Life
      • CRC Prevention Resources
      • CRC Risk Calculator
      • Clinical Validation of FIT Test for Colorectal Cancer
      • Rising Use of Multitarget Stool DNA Testing for Colorectal Cancer
      • Prevention, Diagnosis and Treatment Resources
      • FIT Tests: What You Need to Know
    • CRC Survivor Stories
      • Digital Storytelling
      • Survivor’s Television Story
  • ABOUT C4
    • President’s Message
    • Board
  • NEWS & EVENTS
    • 80% in Every Community
    • CA Achievement Award
    • COVID-19 Webinar
    • Increasing Screenings in San Diego County
  • DONATE
    • Our Donors
    • Conflict of Interest Statement
    • Amazon Smile
    • Spotfund – Screening for Colorectal Cancer
  • OUR WORK
    • 2022 Community Grants
    • 2020 Community Grants
    • 2019 Community Grants
    • 2018 Community Grants
    • CRC Webinar
    • Past Grant Awardees
    • WC4 Conference
Contact Us

Colorectal Cancer Screening Reference List

Screening Guidelines

1a.  Bibbins-Domingo K, Grossman DC, Curry SJ, et al; US Preventive Services Task Force. Screening for colorectal cancer: US PreventiveServices Task Force recommendation statement. JAMA. 2016;315:2564-75. [PMID: 27304597] doi:10.1001/jama.2016.5989

https://jamanetwork.com/journals/jama/fullarticle/2529486

1b.  Lin JS, Piper MA, Perdue LA, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2016;315:2576-94. [PMID:27305422] doi:10.1001/jama.2016.3332

https://jamanetwork.com/journals/jama/fullarticle/2529492

1c.  Qaseem A et al: Screening for colorectal cancer in asymptomatic average-risk adults: a guidance statement from the American College of Physicians. Ann Intern Med. 2019; 171(9):643-54

https://www.acpjournals.org/doi/full/10.7326/M19-0642?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&

1d.  Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology.2017;152:1217-1237.e3. [PMID: 27769517] doi:10.1053/j.gastro.2016.08.053

https://www.gastrojournal.org/article/S0016-5085(16)35025-9/fulltext?referrer=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F27769517%2F

1e. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017;153:307-23. [PMID:28600072] doi:10.1053/j.gastro.2017.05.01

              Requires a subscription to view the full article:

https://www.gastrojournal.org/article/S0016-5085(17)35599-3/fulltext?referrer=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F28600072%2F

Comparison and Performance of Colorectal Cancer Screening Tests

2a.  Weinberg DS, Barkun A, Turner BJ. Colorectal cancer screening in the United States: what is the best FIT? Ann Intern Med. 2017;166:297-8. [PMID: 27776358] doi:10.7326/M16-2341

              Requires a subscription to view the full article:

https://www.acpjournals.org/doi/full/10.7326/M16-2341

2b.  Imperiale TF, Gruber RN, Stump TE, et al. Performance characteristics of fecal immunochemical tests for colorectal cancer and advanced adenomatous polyps. A systematic review and meta-analysis. Ann Intern Med. 2019. [Epub ahead of print].doi:10.7326/M18-2390

              Requires a subscription to view the full article:

https://www.acpjournals.org/doi/full/10.7326/M18-2390

2c.  Allison JE, Fraser CG, Halloran SP, Young GP. Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver. 2014;8:117-30. [PMID:24672652] doi:10.5009/gnl.2014.8.2.117

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964261/

2d.  Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of Fecal Immunochemical Tests for Colorectal Cancer: Systematic Review and Meta-analysis. Ann Intern Med. 2014 February 4; 160(3): 171. doi:10.7326/M13-1484.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189821/

2e.  Allison JE. Why What You May Not Know About Fecal Immunochemical Testing Matters. Ann Intern Med. doi:10.7326/M19-0301

https://www.acpjournals.org/doi/pdf/10.7326/M19-0301

2f. Ladabaum U, Mannalithara A. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia. Gastroenterology 2016;151:427–439

https://www.gastrojournal.org/article/S0016-5085(16)34617-0/fulltext?referrer=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F27311556%2F

2g.  Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening. N Engl J Med 2012;366:697-706.

https://www.nejm.org/doi/full/10.1056/nejmoa1108895

2h.  Jensen CD, Corley DA, Quinn VP, et al. Fecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort study. Ann Intern Med 2016;164:456–463.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973858/

2i.  Tinmouth J, Lansdorp-Vogelaar I, Allison JE. Fecal immunochemical tests versus guaiac fecal occult blood tests: what clinicians and colorectal cancer screening program organizers need to know. Gut 2015;64:1327–1337.

Requires a subscription to view the full article:

https://gut.bmj.com/content/64/8/1327.full

Colonoscopy Screening Long-Term Protection from Colorectal Cancer

3a. Pilonis ND, Bugajski M, Wieszczy P, et al. Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy. Ann Intern Med 2020. doi:10.7326/M19-2477

Requires a subscription to view the full article:

https://www.acpjournals.org/doi/abs/10.7326/M19-2477?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=aim

Strategies to Increase Colorectal Cancer Screening

4a.  Sarfaty M, Doroshenk M, Hotz J, et al. Strategies for expanding colorectal cancer screening at community health centers. CA Cancer J Clin; 2013; 63 (4): 221-31

https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21191

4b.  Weiner BJ, Rohweder CL, Scott JE, Teal R, et al. Using Practice Facilitation to Increase Rates of Colorectal Cancer Screening in Community Health Centers North Carolina 2012–2013∫Feasibility Facilitators and Barriers. Prev Chronic Dis 2017;14:1-7.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566800/

4c. Dougherty MK, Brenner AT, et al. Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States A Systematic Review and Meta-analysis. JAMA Intern Med. 2018;178(12):1645-1658. doi:10.1001/jamainternmed.2018.4637

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583619/

4d.  Potter MB, Ackerson LM, Gomez V, et al. Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial. Am J Public Health. 2013;103:1128–1133. doi:10.2105/AJPH.2012.300998)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670663/

4e.   Potter MB, Walsh JM, Yu TM, et al The effectiveness of the FLU-FOBT Program in primary care: A randomized trial. Am J Prev Med. 2011;41:9-16.

https://www.ajpmonline.org/article/S0749-3797(11)00223-6/fulltext

4f.  Web site and information on FLU/FIT Programs

FluFit Program

4g.  Castañeda SF, Bharti B, Rojas M, Gupta S. Cancer Screening Among Latinos at a Federally Qualified Health Center: A Randomized Controlled Trial, 2015–2018. Am J Public Health. 2020;110:587–594.doi:10.2105/AJPH.2019.305524)

https://ajph.aphapublications.org/doi/full/10.2105/AJPH.2019.305524

4h. Coronado GD, Petrik AF, Vollmer WM, et al.  Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics.  The STOP CRC Cluster Randomized Clinical Trial. JAMA Intern Med. 2018;178(9):1174-1181. doi:10.1001/jamainternmed.2018.3629

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142956/

4i.  Kemper KE, Glaze BL, Eastman CL, et al. Effectiveness and Cost of Multilayered Colorectal Cancer Screening Promotion Interventions at Federally Qualified Health Centers in Washington State. Cancer 2018;124:4121-4129.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263795/

4J.  Gupta, S, Coronado GD, Argenbright, Brenner, A, Castaneda, SF et al. Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention–sponsored summit. CA Cancer J Clin 2020 Jun 25. doi:10.3322/caac.21615.

CA Cancer J Clin . 2020 Jun 25. doi: 10.3322/caac.21615


4K.  Overview to increase colorectal cancer screening:  
https://www.cdc.gov/cancer/colorectal/quality/index.htm

Necessary Strategies to Ensure the Required Colonoscopy is Done After an Abnormal FIT Test

5a.  Corley DA, Jensen CD, Quinn VP, et al. Association Between Time to Colonoscopy After a Positive Fecal Test and Risk of Colorectal Cancer Stage at Diagnosis. JAMA 2017;317(16):1631-1641

https://jamanetwork.com/journals/jama/fullarticle/2620087

5b.  Selby K, Baumgartner C, MD, Levin TR, et al. Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests Ann Intern Med 2017;167(8):565-575

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178946/

5c.  Bharti B, May FP, Nodora J, Martinez, ME, et al. Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes. Cancer,2019;125(23):4203-4209

Requires a subscription to view the full article:

https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32440

Colorectal Cancer Incidence and Mortality Reduction from Organized Screening

6a.  Levin TR, Corley DA, Jensen CD, et al. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large ommunity-Based Population Gastroenterology 2018;155:1383–1391

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240353/

Excellent Review of Colon Adenomatous Polyps

7a.  Strum WB. Colorectal Adenomas. N Engl J Med 2016;374:1065-75. DOI: 10.1056/NEJMra1513581

Requires a subscription to view the full article:

https://www.nejm.org/doi/full/10.1056/NEJMra1513581?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

Follow C4 on Twitter

My Tweets
California Colorectal Cancer Coalition | 2253 Soledad Rancho Rd. San Diego Ca 92109 | 619-316-8751 | Federal Tax ID: 95-3102332
TOP